TP53 and neoplasm: One plausible scenario based on the intestinal differentiation assay, is that the CNOT3 E70K inactivating mutation could be working with APC mutation to better prevent differentiation while waiting for other tumor-promoting mutations in KRAS and TP53 to occur [10, 11].